Peanuts Linked to Lower Diabetes Risk

A trial and cohort study tie daily peanut intake to changes in blood fats associated with reduced type 2 diabetes risk.

Updated on Nov. 11, 2026 in Nutrition

A bowl of shelled peanuts beside small glass vials on a pale wooden laboratory bench, evoking research on diet and blood fats.
A University of Barcelona study found daily peanut consumption raised blood fats linked to an 11% lower type 2 diabetes risk in the EPIC-Potsdam cohort. AI Illustration. Upload story photo >

Live Poll

Would you change your snacking habits if you learned they could lower diabetes risk?

Researchers at the University of Barcelona found that daily peanut consumption raised circulating very long-chain saturated fatty acids in participants' blood lipids over six months. In the EPIC-Potsdam cohort, those lipid changes were associated with an 11% lower risk of type 2 diabetes.

Why it matters

The findings suggest a biological pathway through which peanut intake may relate to diabetes risk, offering a more specific explanation than general dietary associations. Readers should note the study's observational component and the involvement of a peanut industry-funded foundation.

The evidence combines a six-month randomized trial of 63 healthy young adults eating 25 g of roasted peanuts or 32 g of peanut butter daily with a cohort analysis of 774 type 2 diabetes cases, which linked peanut-related lipid changes to an 11% lower risk. Whether the lipid changes themselves drive the reduction remains unclear, since body mass index accounted for much of the association.

The players

The American Journal of Clinical Nutrition

A peer-reviewed journal published by the American Society for Nutrition that covers research on diet and human health.

The Peanut Institute Foundation

A funder of the ARISTOTLE study whose support for peanut research means its interest in the findings should be weighed alongside the study's results.

The details

Investigators derived a peanut lipidomic signature from blood lipids responsive to peanut fat in the ARISTOTLE trial and then applied it to the EPIC-Potsdam cohort. The study was funded by The Peanut Institute Foundation and published in The American Journal of Clinical Nutrition.

Timeline

  1. The peanut intervention in the ARISTOTLE trial lasted six months.

  2. Findings were published online on November 10, 2026.

Health Landscape

The study extends the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort work by pairing observational data with a controlled trial to test a specific nutritional biomarker. This approach moves beyond general dietary associations toward mechanism-level evidence in diabetes prevention research.

For adults who already eat peanuts, the findings suggest that moderate intake may be compatible with diabetes prevention, though the study does not establish a dosage recommendation. Readers considering dietary changes should consult a clinician, especially given the funding disclosure and the trial's small, young, healthy sample.

The takeaway

Peanut-related changes in blood fats may help explain part of the observed link between nut intake and lower diabetes risk, but body weight appears to account for much of the effect. Further research in larger and more diverse populations is needed before drawing firm dietary conclusions.

Further reading

Explore more on Nutrition for context on how everyday foods affect metabolic health.

Source note: This article includes information reported by Eurasia Review.

Live Poll

Would you change your snacking habits if you learned they could lower diabetes risk?